Updated Jul 16, 2026
GELLER EHUD has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Ehud Geller is identified in SEC filings as the Chief Executive Officer of Regentis Biomaterials Ltd, with the most recent filing dated July 13, 2026. In this capacity, he is described as the leader responsible for the company's strategic direction and day-to-day operations, in the context of Regentis Biomaterials' activities in the biomaterials sector.
| Role | Chief Executive Officer, Director |
|---|---|
| Notability | 45/100 |
Ehud Geller is identified in SEC filings as the Chief Executive Officer of Regentis Biomaterials Ltd, with the most recent filing dated July 13, 2026. In this capacity, he is described as the leader responsible for the company's strategic direction and day-to-day operations, in the context of Regentis Biomaterials' activities in the biomaterials sector.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live GELLER EHUD profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.